Follow the カルナバイオサイエンス株式会社 share price and the full management transaction log of the company, a listed equity based in Japan. Shares trade on JP JP, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, カルナバイオサイエンス株式会社 has recorded 26 insider filings. Market capitalisation: €5.7bn. The latest transaction was filed on 29 July 2026 (Holding update). Among the most active insiders: Cantor Fitzgerald & Co.. Every trade is accessible without an account.
26
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
32Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,689 of 28,064 companies
23.9
score / 100
Value
6
Quality
42
FCF yld-37%
Earn yld-37%
EV/EBITDA·
ROE-244%
Gross mgn67%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.